K2 HealthVentures Launches New Investment Company with Industry-Leading Team and $400 Million Initial Capital Commitment

May 21, 2019

-- Will seek to advance development and fuel growth of life sciences and healthcare companies with dual goals of profit and purpose --

K2 HealthVentures (K2HV) announced today the launch of a new specialty finance company that will provide long-term debt, equity, and intellectual capital to private and public life sciences and healthcare companies. With substantial initial funding and a permanent capital base, which is expected to grow significantly over time, the firm will initially target investments ranging in size from $10-50 million. A key principle of K2HV’s charter is its commitment to devoting a portion of investment profits to fund underserved and underinvested areas in the healthcare space, both in the US and globally.

Read full press release